The unrecognized prevalence of chronic kidney disease in diabetes

Background. Diabetes mellitus and chronic kidney disease (CKD) are common and exhibit synergistic associations with premature mortality. Current diabetes guidelines in the UK recommend annual urinary albumin and serum creatinine determinations to screen for diabetic kidney disease. The aim of this s...

Full description

Saved in:
Bibliographic Details
Published inNephrology, dialysis, transplantation Vol. 21; no. 1; pp. 88 - 92
Main Authors Middleton, Rachel J., Foley, Robert N., Hegarty, Janet, Cheung, Ching M., McElduff, Patrick, Gibson, J. Martin, Kalra, Philip A., O'Donoghue, Donal J., New, John P.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.01.2006
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text
ISSN0931-0509
1460-2385
DOI10.1093/ndt/gfi163

Cover

More Information
Summary:Background. Diabetes mellitus and chronic kidney disease (CKD) are common and exhibit synergistic associations with premature mortality. Current diabetes guidelines in the UK recommend annual urinary albumin and serum creatinine determinations to screen for diabetic kidney disease. The aim of this study was to estimate the burden of CKD in patients with diabetes and examine the ability of serum creatinine and albuminuria to detect clinically meaningful CKD compared with estimated glomerular filtration rate (eGFR). Methods. All adults known to have diabetes in primary and secondary care in Salford, UK, alive with independent renal function on 1 January 2004 were included in this observational study (n = 7596). Demographic and laboratory parameters were obtained from the Electronic Patient Record. eGFR was determined using the 4-variable modification of diet in renal disease (MDRD) formula. Clinically meaningful CKD was defined as an eGFR <60 ml/min/1.73 m2. Results. Creatinine and albuminuria were measured in the preceding 2 years in 82.3 and 55.2% of subjects, respectively. In patients with CKD, normoalbuminuria was present in 48.8%, and serum creatinine was normal (≤120 µmol/l) in 54.7%. An abnormal serum creatinine (≥120 µmol/l) had a sensitivity and specificity of 45.3 and 100%, respectively, to identify CKD. The combination of abnormal creatinine and albuminuria had an improved performance but still failed to detect a large number with CKD (sensitivity 82.4%, specificity 75.4%). Serum creatinine failed to identify CKD more often in females (OR 8.22, CI 6.56–10.29). Conclusions. Undiagnosed CKD is common in diabetes. Current screening strategies, based on creatinine or albuminuria, fail to identify a considerable number of subjects with CKD. Incorporating eGFR into screening for CKD would identify individuals earlier in the natural history of the disease and enable early effective treatment to delay progression of CKD.
Bibliography:local:gfi163
Corresponding and offprint requests to: Rachel J. Middleton, Specialist Registrar in Nephrology, Department of Renal Medicine, Hope Hospital, Stott Lane, Salford M6 8HD, UK. Email: Rachel.middleton@srht.nhs.uk
istex:9E0849B6BB4EEAFB3B32A6F7C3AC59474DE3AC14
ark:/67375/HXZ-G3M3CZKK-7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfi163